デフォルト表紙
市場調査レポート
商品コード
1482397

化粧品CDMO市場:製品タイプ、エンドユーザー、地域別(北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカ):世界の産業分析、規模、シェア、成長、動向、2024年~2032年予測

Cosmetic CDMO Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

出版日: | 発行: Persistence Market Research | ページ情報: 英文 288 Pages | 納期: 2~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.53円
化粧品CDMO市場:製品タイプ、エンドユーザー、地域別(北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカ):世界の産業分析、規模、シェア、成長、動向、2024年~2032年予測
出版日: 2024年05月13日
発行: Persistence Market Research
ページ情報: 英文 288 Pages
納期: 2~5営業日
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社は、化粧品CDMO市場の徹底的な分析を実施し、その世界の展望を詳述した包括的なレポートを提供しています。この詳細な出版物は、市場力学、動向、機会、課題に関する貴重な洞察を提供し、その構造の包括的な概要を提供します。独占データと統計に裏打ちされた本調査は、2024年から2032年までの化粧品CDMO市場の予想成長軌道を予測しています。

2024年、化粧品CDMO市場の世界収益は約226億4,000万米ドルに達しました。市場推計・予測では、著しい成長を示唆しており、市場はCAGR5.5%で拡大し、2032年には347億6,000万米ドルに達すると予測されています。

主な洞察

  • 化粧品CDMO市場規模(2024年):米国:226億4,000万米ドル
  • 予測市場価値(2032年)米国:347億6,000万米ドル
  • 世界市場成長率(CAGR 2024年~2032年):5.5%

化粧品CDMO市場- 調査範囲:

化粧品CDMOサービスは、様々なブランドや企業の化粧品開発・製造において重要な役割を果たしています。これらのサービスは、処方開発、製造、パッケージング、規制遵守を含む幅広い活動を包含しています。化粧品CDMO市場は、化粧品ブランド、スキンケア企業、パーソナルケア製品メーカーに対応し、それぞれのニーズや要件に合わせたソリューションを提供しています。

市場の成長は、カスタマイズされた化粧品に対する需要の増加、製造業務のアウトソーシング傾向の高まり、製品のイノベーションと品質への注目の高まりなど、いくつかの要因によってもたらされます。さらに、化粧品の処方や技術の進歩、消費者の嗜好やライフスタイルの動向の変化も市場拡大に寄与しています。

市場促進要因:

カスタマイズされた化粧品への需要の高まり

製造業務のアウトソーシング傾向の高まり

製品の革新性と品質の重視

化粧品の処方と技術の進歩

市場抑制要因:

規制上の課題とコンプライアンス要件

価格圧力とコスト制約

激しい競争と市場統合

市場機会

新興市場への進出

サービス提供の多様化

戦略的パートナーシップと提携

技術の進歩と革新

本レポートで扱う主な質問

  • 化粧品CDMO市場の世界の成長を促進する主な要因は何か?
  • 化粧品ブランドやメーカーの間で需要の高いサービスやソリューションは何か?
  • 技術の進歩は化粧品CDMO市場の競合情勢をどのように変えているのか?
  • 化粧品CDMO市場に貢献している主要企業はどこか、また市場の関連性を維持するためにどのような戦略をとっているのか?
  • 世界の化粧品CDMO市場の新たな動向と将来性は?

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 キーインクルージョン

  • 規制シナリオ
  • バリューチェーン分析
  • PESTLE分析
  • ポーターの分析
  • 製品の採用/使用状況分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19の現在の統計と今後の影響の可能性
  • 現在のGDP予測と予想される影響
  • COVID19の影響分析
    • サービス別
    • 製品別
    • フォーム別
    • 地域別

第7章 世界の化粧品CDMO市場の需要分析

  • 過去の市場金額分析、2019年~2023年
  • 現在および将来の市場金額予測、2024年~2032年
    • 前年比成長動向分析
    • 絶対的な機会分析

第8章 世界の化粧品CDMO市場分析、サービス別

  • イントロダクション/主な調査結果
  • 2019年~2023年のサービス別市場規模の歴史的分析
  • 現在および将来の市場規模の分析と予測、サービス別、2024年~2032年
    • 契約開発
      • 処方開発
      • パイロットスタディ
    • 契約製造
      • バルク準備とスケールアップ
      • 安全性試験
      • 充填と包装
        • 瓶を閉じる
        • ボトル
        • チューブ
        • ロールオン
        • その他
  • サービス別市場魅力度分析

第9章 世界の化粧品CDMO市場分析、製品別

  • イントロダクション
  • 2019年~2023年製品別市場規模の歴史的分析
  • 現在および将来の市場規模分析と予測、製品別、2024年~2032年
    • リップ
    • 体の衛生
    • 口腔衛生
    • その他
  • 製品別市場魅力度分析

第10章 世界の化粧品CDMO市場分析、形態別

  • イントロダクション
  • 過去の市場規模の形態別分析
  • 現在および将来の市場規模の分析と予測、2024年~2032年
    • 固形および粉末
    • ローション
    • クリーム
    • その他
  • 形態別市場魅力度分析

第11章 世界化粧品CDMO市場分析、地域別

  • イントロダクション
  • 地域別市場規模の歴史的分析、2019年~2023年
  • 現在および将来の市場規模の地域別分析と予測、2024年~2032年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東・アフリカ
  • 地域別市場魅力度分析

第12章 北米の化粧品CDMO市場分析

第13章 ラテンアメリカの化粧品CDMO市場分析

第14章 欧州の化粧品CDMO市場分析

第15章 南アジアの化粧品CDMO市場分析

第16章 東アジアの化粧品CDMO市場分析

第17章 オセアニアの化粧品CDMO市場分析

第18章 中東・アフリカの化粧品CDMO市場分析

第19章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第20章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Swiss American CDMO
    • Pierre Fabre Group
    • Zymo Cosmetics
    • Fareva
    • Biofarma Srl CF
    • Chemineau
    • COC Farmaceutici Srl
    • PARAGON NORDIC
    • Cosmetic Solutions
    • Kolmar
    • Lonza
    • Cho Chuang Industrial Co., Ltd.
    • Vive Cosmetics
    • Ori BioNature Sdn Bhd
    • Zoic Cosmetics
    • Samriddhi Life Sciences
    • Natrocare

第21章 使用される仮定と頭字語

第22章 調査方法論

目次
Product Code: PMRREP33181

Persistence Market Research has conducted a thorough analysis of the Cosmetic CDMO Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the Cosmetic CDMO Market spanning from 2024 to 2032.

In 2024, the global revenue from the cosmetic CDMO market reached approximately US$22.64 billion. Projections suggest significant growth, with the market expected to expand at a compound annual growth rate (CAGR) of 5.5%, reaching an estimated value of US$34.76 billion by 2032.

Key Insights:

  • Cosmetic CDMO Market Size (2024): US$22.64 billion
  • Projected Market Value (2032): US$34.76 billion
  • Global Market Growth Rate (CAGR 2024-2032): 5.5%

Cosmetic CDMO Market - Report Scope:

Cosmetic CDMO services play a crucial role in the development and manufacturing of cosmetic products for various brands and companies. These services encompass a wide range of activities, including formulation development, manufacturing, packaging, and regulatory compliance. The cosmetic CDMO market caters to cosmetic brands, skincare companies, and personal care product manufacturers, offering tailored solutions to meet their specific needs and requirements.

Market growth is driven by several factors, including the increasing demand for customized cosmetic products, the growing trend towards outsourcing manufacturing activities, and the rising focus on product innovation and quality. Additionally, advancements in cosmetic formulations and technologies, coupled with changing consumer preferences and lifestyle trends, contribute to market expansion.

Market Growth Drivers:

Growing demand for customized cosmetic products

Increasing trend towards outsourcing manufacturing activities

Emphasis on product innovation and quality

Advancements in cosmetic formulations and technologies

Market Restraints:

Regulatory challenges and compliance requirements

Pricing pressures and cost constraints

Intense competition and market consolidation

Market Opportunities:

Expansion into emerging markets

Diversification of service offerings

Strategic partnerships and collaborations

Technological advancements and innovation

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the cosmetic CDMO market globally?
  • Which services and solutions are in high demand among cosmetic brands and manufacturers?
  • How are technological advancements reshaping the competitive landscape of the cosmetic CDMO market?
  • Who are the key players contributing to the cosmetic CDMO market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global cosmetic CDMO market?

Competitive Intelligence and Business Strategy:

Leading players in the global cosmetic CDMO market focus on innovation, service differentiation, and strategic collaborations to gain a competitive edge. These companies invest in research and development to develop advanced formulations and manufacturing processes, catering to diverse client requirements and market demands. Collaborations with cosmetic brands, regulatory agencies, and industry partners facilitate market access and promote business growth.

Companies Covered in This Report -

  • Swiss American CDMO
  • Pierre Fabre Group
  • Zymo Cosmetics
  • Fareva
  • Biofarma Srl C.F
  • Chemineau
  • C.O.C. Farmaceutici Srl
  • PARAGON NORDIC
  • Cosmetic Solutions
  • Kolmar
  • Lonza
  • Cho Chuang Industrial Co., Ltd.
  • Vive Cosmetics
  • Ori BioNature Sdn Bhd
  • Zoic Cosmetics
  • Samriddhi Life Sciences
  • Natrocare

Key Segments Covered in Cosmetic CDMO Industry Research

By Service:

  • Contract Development
  • Contract Manufacturing

By Product:

  • Hair Products
  • Skin Products
  • Lip Products
  • Eye Products
  • Body Hygiene
  • Oral Hygiene

By Form:

  • Solid Form & Powder
  • Lotions
  • Creams
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Influencing the Market
  • 3.2. Product Innovation / Development Trends

4. Key Inclusion

  • 4.1. Regulatory Scenario
  • 4.2. Value Chain Analysis
  • 4.3. PESTLE Analysis
  • 4.4. Porter's Analysis
  • 4.5. Product Adoption/Usage Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Spending Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Product adoption rate
    • 5.2.2. Increased prevalence rate of key players
    • 5.2.3. Cost of manufacturing
    • 5.2.4. Increase Research and Development
    • 5.2.5. Availability of products
    • 5.2.6. Regulatory scenario
    • 5.2.7. Increased acquisition and mergers
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. Current COVID-19 Statistics and Probable Future Impact
  • 6.2. Current GDP Projection and Probable Impact
  • 6.3. COVID19 Impact Analysis
    • 6.3.1. By Service
    • 6.3.2. By Product
    • 6.3.3. By Form
    • 6.3.4. By Region

7. Global Cosmetic CDMO Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2032

  • 7.1. Historical Market Value (US$ Mn) Analysis 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Cosmetic CDMO Market Analysis 2019-2023 and Forecast 2024-2032, By Service

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis by Service, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Service, 2024-2032
    • 8.3.1. Contract Development
      • 8.3.1.1. Formulation Development
      • 8.3.1.2. Pilot Studies
    • 8.3.2. Contract Manufacturing
      • 8.3.2.1. Bulk Preparation & Scale Up
      • 8.3.2.2. Safety Testing
      • 8.3.2.3. Filling & Packaging
        • 8.3.2.3.1. Close Jar
        • 8.3.2.3.2. Bottles
        • 8.3.2.3.3. Tubes
        • 8.3.2.3.4. Roll Ons
        • 8.3.2.3.5. Others
  • 8.4. Market Attractiveness Analysis by Service

9. Global Cosmetic CDMO Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) Analysis by Product, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product, 2024-2032
    • 9.3.1. Hair
    • 9.3.2. Skin
    • 9.3.3. Lip
    • 9.3.4. Eye
    • 9.3.5. Body Hygiene
    • 9.3.6. Oral Hygiene
    • 9.3.7. Others
  • 9.4. Market Attractiveness Analysis by Product

10. Global Cosmetic CDMO Market Analysis 2019-2023 and Forecast 2024-2032, By Form

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis by Form
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Form, 2024-2032
    • 10.3.1. Solid Form and Powder
    • 10.3.2. Lotions
    • 10.3.3. Creams
    • 10.3.4. Others
  • 10.4. Market Attractiveness Analysis by Form

11. Global Cosmetic CDMO Market Analysis 2019-2023 and Forecast 2024-2032, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2032
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. South Asia
    • 11.3.5. East Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East & Africa
  • 11.4. Market Attractiveness Analysis by Region

12. North America Cosmetic CDMO Market Analysis 2019-2023 and Forecast 2024-2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Service
    • 12.3.3. By Product
    • 12.3.4. By Form
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Service
    • 12.4.3. By Product
    • 12.4.4. By Form
  • 12.5. Key Market Participants - Intensity Mapping
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Country Level Analysis & Forecast
    • 12.7.1. U.S. Cosmetic CDMO Market
      • 12.7.1.1. Introduction
      • 12.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.7.1.2.1. By Service
        • 12.7.1.2.2. By Product
        • 12.7.1.2.3. By Form
    • 12.7.2. Canada Cosmetic CDMO Market
    • 12.7.3. Introduction
    • 12.7.4. Market Analysis and Forecast by Market Taxonomy
      • 12.7.4.1. By Service
      • 12.7.4.2. By Product
      • 12.7.4.3. By Form

13. Latin America Cosmetic CDMO Market Analysis 2019-2023 and Forecast 2024-2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Service
    • 13.3.3. By Product
    • 13.3.4. By Form
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Service
    • 13.4.3. By Product
    • 13.4.4. By Form
  • 13.5. Key Market Participants - Intensity Mapping
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Country Level Analysis & Forecast
    • 13.7.1. Brazil Cosmetic CDMO Market
      • 13.7.1.1. Introduction
      • 13.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.7.1.2.1. By Service
        • 13.7.1.2.2. By Product
        • 13.7.1.2.3. By Form
    • 13.7.2. Mexico Cosmetic CDMO Market
      • 13.7.2.1. Introduction
      • 13.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.7.2.2.1. By Service
        • 13.7.2.2.2. By Product
        • 13.7.2.2.3. By Form
    • 13.7.3. Argentina Cosmetic CDMO Market
    • 13.7.4. Introduction
    • 13.7.5. Market Analysis and Forecast by Market Taxonomy
      • 13.7.5.1. By Service
      • 13.7.5.2. By Product
      • 13.7.5.3. By Form

14. Europe Cosmetic CDMO Market Analysis 2019-2023 and Forecast 2024-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. Benelux
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Service
    • 14.3.3. By Product
    • 14.3.4. By Form
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Service
    • 14.4.3. By Product
    • 14.4.4. By Form
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. Germany Cosmetic CDMO Market
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.1.2.1. By Service
        • 14.7.1.2.2. By Product
        • 14.7.1.2.3. By Form
    • 14.7.2. Italy Cosmetic CDMO Market
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.2.2.1. By Service
        • 14.7.2.2.2. By Product
        • 14.7.2.2.3. By Form
    • 14.7.3. France Cosmetic CDMO Market
      • 14.7.3.1. Introduction
      • 14.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.3.2.1. By Service
        • 14.7.3.2.2. By Product
        • 14.7.3.2.3. By Form
    • 14.7.4. U.K. Cosmetic CDMO Market
      • 14.7.4.1. Introduction
      • 14.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.4.2.1. By Service
        • 14.7.4.2.2. By Product
        • 14.7.4.2.3. By Form
    • 14.7.5. Spain Cosmetic CDMO Market
      • 14.7.5.1. Introduction
      • 14.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.5.2.1. By Service
        • 14.7.5.2.2. By Product
        • 14.7.5.2.3. By Form
    • 14.7.6. Benelux Cosmetic CDMO Market
      • 14.7.6.1. Introduction
      • 14.7.6.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.6.2.1. By Service
        • 14.7.6.2.2. By Product
        • 14.7.6.2.3. By Form
    • 14.7.7. Russia Cosmetic CDMO Market
      • 14.7.7.1. Introduction
      • 14.7.7.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.7.2.1. By Service
        • 14.7.7.2.2. By Product
        • 14.7.7.2.3. By Form

15. South Asia Cosmetic CDMO Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Indonesia
      • 15.3.1.3. Malaysia
      • 15.3.1.4. Thailand
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Service
    • 15.3.3. By Product
    • 15.3.4. By Form
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By country
    • 15.4.2. By Service
    • 15.4.3. By Product
    • 15.4.4. By Form
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. India Cosmetic CDMO Market
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.1.2.1. By Service
        • 15.7.1.2.2. By Product
        • 15.7.1.2.3. By Form
    • 15.7.2. Indonesia Cosmetic CDMO Market
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.2.2.1. By Service
        • 15.7.2.2.2. By Product
        • 15.7.2.2.3. By Form
    • 15.7.3. Malaysia Cosmetic CDMO Market
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.3.2.1. By Service
        • 15.7.3.2.2. By Product
        • 15.7.3.2.3. By Form
    • 15.7.4. Thailand Cosmetic CDMO Market
      • 15.7.4.1. Introduction
      • 15.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.4.2.1. By Service
        • 15.7.4.2.2. By Product
        • 15.7.4.2.3. By Form

16. East Asia Cosmetic CDMO Market Analysis 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Service
    • 16.3.3. By Product
    • 16.3.4. By Form
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Service
    • 16.4.3. By Product
    • 16.4.4. By Form
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. China Cosmetic CDMO Market
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.1.2.1. By Service
        • 16.7.1.2.2. By Product
        • 16.7.1.2.3. By Form
    • 16.7.2. Japan Cosmetic CDMO Market
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.2.2.1. By Service
        • 16.7.2.2.2. By Product
        • 16.7.2.2.3. By Form
    • 16.7.3. South Korea Cosmetic CDMO Market
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.3.2.1. By Service
        • 16.7.3.2.2. By Product
        • 16.7.3.2.3. By Form

17. Oceania Cosmetic CDMO Market Analysis 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Service
    • 17.3.3. By Product
    • 17.3.4. By Form
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Service
    • 17.4.3. By Product
    • 17.4.4. By Form
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. Australia Cosmetic CDMO Market
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.1.2.1. By Service
        • 17.7.1.2.2. By Product
        • 17.7.1.2.3. By Form
    • 17.7.2. New Zealand Cosmetic CDMO Market
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.2.2.1. By Service
        • 17.7.2.2.2. By Product
        • 17.7.2.2.3. By Form

18. Middle East and Africa Cosmetic CDMO Market Analysis 2019-2023 and Forecast 2024-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. Rest of Middle East and Africa
    • 18.3.2. By Service
    • 18.3.3. By Product
    • 18.3.4. By Form
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Service
    • 18.4.3. By Product
    • 18.4.4. By Form
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. GCC Countries Cosmetic CDMO Market
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.1.2.1. By Service
        • 18.7.1.2.2. By Product
        • 18.7.1.2.3. By Form
    • 18.7.2. Turkey Cosmetic CDMO Market
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.2.2.1. By Service
        • 18.7.2.2.2. By Product
        • 18.7.2.2.3. By Form
    • 18.7.3. South Africa Cosmetic CDMO Market
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.3.2.1. By Service
        • 18.7.3.2.2. By Product
        • 18.7.3.2.3. By Form

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis
    • 19.3.1. Regional Footprint of Players
    • 19.3.2. Channel Foot Print by Players

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Swiss American CDMO
      • 20.3.1.1. Overview
      • 20.3.1.2. Product Portfolio
      • 20.3.1.3. Key financials
      • 20.3.1.4. Key Developments
      • 20.3.1.5. SWOT Analysis
      • 20.3.1.6. Strategy Overview
        • 20.3.1.6.1. Product strategy
        • 20.3.1.6.2. Channel Strategy
        • 20.3.1.6.3. Market strategy
    • 20.3.2. Pierre Fabre Group
      • 20.3.2.1. Overview
      • 20.3.2.2. Product Portfolio
      • 20.3.2.3. Key financials
      • 20.3.2.4. Key Developments
      • 20.3.2.5. SWOT Analysis
      • 20.3.2.6. Strategy Overview
        • 20.3.2.6.1. Product strategy
        • 20.3.2.6.2. Channel Strategy
        • 20.3.2.6.3. Market strategy
    • 20.3.3. Zymo Cosmetics
      • 20.3.3.1. Overview
      • 20.3.3.2. Product Portfolio
      • 20.3.3.3. Key financials
      • 20.3.3.4. Key Developments
      • 20.3.3.5. SWOT Analysis
      • 20.3.3.6. Strategy Overview
        • 20.3.3.6.1. Product strategy
        • 20.3.3.6.2. Channel Strategy
        • 20.3.3.6.3. Market strategy
    • 20.3.4. Fareva
      • 20.3.4.1. Overview
      • 20.3.4.2. Product Portfolio
      • 20.3.4.3. Key financials
      • 20.3.4.4. Key Developments
      • 20.3.4.5. SWOT Analysis
      • 20.3.4.6. Strategy Overview
        • 20.3.4.6.1. Product strategy
        • 20.3.4.6.2. Channel Strategy
        • 20.3.4.6.3. Market strategy
    • 20.3.5. Biofarma Srl C.F
      • 20.3.5.1. Overview
      • 20.3.5.2. Product Portfolio
      • 20.3.5.3. Key financials
      • 20.3.5.4. Key Developments
      • 20.3.5.5. SWOT Analysis
      • 20.3.5.6. Strategy Overview
        • 20.3.5.6.1. Product strategy
        • 20.3.5.6.2. Channel Strategy
        • 20.3.5.6.3. Market strategy
    • 20.3.6. Chemineau
      • 20.3.6.1. Overview
      • 20.3.6.2. Product Portfolio
      • 20.3.6.3. Key financials
      • 20.3.6.4. Key Developments
      • 20.3.6.5. SWOT Analysis
      • 20.3.6.6. Strategy Overview
        • 20.3.6.6.1. Product strategy
        • 20.3.6.6.2. Channel Strategy
        • 20.3.6.6.3. Market strategy
    • 20.3.7. C.O.C. Farmaceutici Srl
      • 20.3.7.1. Overview
      • 20.3.7.2. Product Portfolio
      • 20.3.7.3. Key financials
      • 20.3.7.4. Key Developments
      • 20.3.7.5. SWOT Analysis
      • 20.3.7.6. Strategy Overview
        • 20.3.7.6.1. Product strategy
        • 20.3.7.6.2. Channel Strategy
        • 20.3.7.6.3. Market strategy
    • 20.3.8. PARAGON NORDIC
      • 20.3.8.1. Overview
      • 20.3.8.2. Product Portfolio
      • 20.3.8.3. Key financials
      • 20.3.8.4. Key Developments
      • 20.3.8.5. SWOT Analysis
      • 20.3.8.6. Strategy Overview
        • 20.3.8.6.1. Product strategy
        • 20.3.8.6.2. Channel Strategy
        • 20.3.8.6.3. Market strategy
    • 20.3.9. Cosmetic Solutions
      • 20.3.9.1. Overview
      • 20.3.9.2. Product Portfolio
      • 20.3.9.3. Key financials
      • 20.3.9.4. Key Developments
      • 20.3.9.5. SWOT Analysis
      • 20.3.9.6. Strategy Overview
        • 20.3.9.6.1. Product strategy
        • 20.3.9.6.2. Channel Strategy
        • 20.3.9.6.3. Market strategy
    • 20.3.10. Kolmar
      • 20.3.10.1. Overview
      • 20.3.10.2. Product Portfolio
      • 20.3.10.3. Key financials
      • 20.3.10.4. Key Developments
      • 20.3.10.5. SWOT Analysis
      • 20.3.10.6. Strategy Overview
        • 20.3.10.6.1. Product strategy
        • 20.3.10.6.2. Channel Strategy
        • 20.3.10.6.3. Market strategy
    • 20.3.11. Lonza
      • 20.3.11.1. Overview
      • 20.3.11.2. Product Portfolio
      • 20.3.11.3. Key financials
      • 20.3.11.4. Key Developments
      • 20.3.11.5. SWOT Analysis
      • 20.3.11.6. Strategy Overview
        • 20.3.11.6.1. Product strategy
        • 20.3.11.6.2. Channel Strategy
        • 20.3.11.6.3. Market strategy
    • 20.3.12. Cho Chuang Industrial Co., Ltd.
      • 20.3.12.1. Overview
      • 20.3.12.2. Product Portfolio
      • 20.3.12.3. Key financials
      • 20.3.12.4. Key Developments
      • 20.3.12.5. SWOT Analysis
      • 20.3.12.6. Strategy Overview
        • 20.3.12.6.1. Product strategy
        • 20.3.12.6.2. Channel Strategy
        • 20.3.12.6.3. Market strategy
    • 20.3.13. Vive Cosmetics
      • 20.3.13.1. Overview
      • 20.3.13.2. Product Portfolio
      • 20.3.13.3. Key financials
      • 20.3.13.4. Key Developments
      • 20.3.13.5. SWOT Analysis
      • 20.3.13.6. Strategy Overview
        • 20.3.13.6.1. Product strategy
        • 20.3.13.6.2. Channel Strategy
        • 20.3.13.6.3. Market strategy
    • 20.3.14. Ori BioNature Sdn Bhd
      • 20.3.14.1. Overview
      • 20.3.14.2. Product Portfolio
      • 20.3.14.3. Key financials
      • 20.3.14.4. Key Developments
      • 20.3.14.5. SWOT Analysis
      • 20.3.14.6. Strategy Overview
        • 20.3.14.6.1. Product strategy
        • 20.3.14.6.2. Channel Strategy
        • 20.3.14.6.3. Market strategy
    • 20.3.15. Zoic Cosmetics
      • 20.3.15.1. Overview
      • 20.3.15.2. Product Portfolio
      • 20.3.15.3. Key financials
      • 20.3.15.4. Key Developments
      • 20.3.15.5. SWOT Analysis
      • 20.3.15.6. Strategy Overview
        • 20.3.15.6.1. Product strategy
        • 20.3.15.6.2. Channel Strategy
        • 20.3.15.6.3. Market strategy
    • 20.3.16. Samriddhi Life Sciences
      • 20.3.16.1. Overview
      • 20.3.16.2. Product Portfolio
      • 20.3.16.3. Key financials
      • 20.3.16.4. Key Developments
      • 20.3.16.5. SWOT Analysis
      • 20.3.16.6. Strategy Overview
        • 20.3.16.6.1. Product strategy
        • 20.3.16.6.2. Channel Strategy
        • 20.3.16.6.3. Market strategy
    • 20.3.17. Natrocare
      • 20.3.17.1. Overview
      • 20.3.17.2. Product Portfolio
      • 20.3.17.3. Key financials
      • 20.3.17.4. Key Developments
      • 20.3.17.5. SWOT Analysis
      • 20.3.17.6. Strategy Overview
        • 20.3.17.6.1. Product strategy
        • 20.3.17.6.2. Channel Strategy
        • 20.3.17.6.3. Market strategy

21. Assumptions and Acronyms Used

22. Research Methodolog